Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neutral postgrafted colloidal particles for gene delivery.

B Thompson1, N Mignet, H Hofland

  • 1CNRS-UMR7001/ENSCP/Gencell S.A., Aventis Pharma, 13 Quai Jules Guesdes, 94403 Vitry-Seine, France.

Bioconjugate Chemistry
|May 19, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The effects of unilateral deprivation amblyopia on fixation stability.

Frontiers in neuroscience·2026
Same author

Investigation of the use of urinary proteomics in the prediction of childhood asthma.

Respiratory medicine·2026
Same author

Glutathione-deficiency promotes basal hyperinsulinemia in the insulin secreting cell line INS-1 (832/13).

Chemico-biological interactions·2026
Same author

Abstracts of the 26th International Workshop on Clinical Pharmacology of HIV, Hepatitis and other Antiviral Drugs 2025, 3-4 September 2025, Amsterdam, the Netherlands.

British journal of clinical pharmacology·2025
Same author

Abstracts of the 26th International Workshop on Clinical Pharmacology of HIV, Hepatitis and other Antiviral Drugs 2025, 3-4 September 2025, Amsterdam, the Netherlands.

British journal of clinical pharmacology·2025
Same author

Implementation of cancer prevention practices in primary care: results of a cohort study in Chile 2018-2022.

Public health·2024

Surface modification of cationic lipoplexes neutralizes their charge, reducing non-specific cell binding and lung accumulation. This approach enables targeted delivery for potential therapeutic applications.

Area of Science:

  • Biochemistry
  • Materials Science
  • Nanotechnology

Background:

  • Cationic lipoplexes are widely used for DNA delivery.
  • Surface charge influences lipoplex interactions with biological systems.
  • Modifying lipoplex surfaces can alter their pharmacokinetic and biodistribution profiles.

Purpose of the Study:

  • To chemically modify the surface of cationic lipoplexes via postgrafting.
  • To investigate the impact of surface neutralization on lipoplex properties and in vivo behavior.
  • To evaluate the potential for targeted delivery using modified lipoplexes.

Main Methods:

  • Postgrafting reaction to modify lipoplex surfaces.
  • Characterization of lipoplex size, zeta potential, and DNA compaction.

Related Experiment Videos

  • In vitro assessment of non-specific cell binding.
  • In vivo biodistribution studies in mice following intravenous injection.

    • Main Results:

    • Surface modification resulted in neutral zeta potential (approx. 0 mV) without altering lipoplex size (~100 nm) or DNA compaction.
    • Non-specific NIH3T3 cell binding was significantly inhibited.
    • Neutralized lipoplexes showed decreased lung accumulation compared to PEGylated cationic lipoplexes.
    • In vivo tumor targeting was achieved by incorporating an RGD-PEG-Cholesterol ligand.

    Conclusions:

    • Surface neutralization of cationic lipoplexes via postgrafting is a viable strategy.
    • This modification reduces non-specific interactions and improves biodistribution.
    • The approach allows for targeted delivery of therapeutic payloads, demonstrated by RGD-mediated tumor targeting.